da Silva-Santos, Y.; Pagni, R.L.; Gamon, T.H.M.; de Azevedo, M.S.P.; Darido, M.L.G.; de Oliveira, D.B.L.; Durigon, E.L.; Luvizotto, M.C.R.; Ackerman, H.C.; Marinho, C.R.F.;
et al. Angiotensin-Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection. Int. J. Mol. Sci. 2025, 26, 7663.
https://doi.org/10.3390/ijms26167663
AMA Style
da Silva-Santos Y, Pagni RL, Gamon THM, de Azevedo MSP, Darido MLG, de Oliveira DBL, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF,
et al. Angiotensin-Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection. International Journal of Molecular Sciences. 2025; 26(16):7663.
https://doi.org/10.3390/ijms26167663
Chicago/Turabian Style
da Silva-Santos, Yasmin, Roberta Liberato Pagni, Thais Helena Martins Gamon, Marcela Santiago Pacheco de Azevedo, Maria Laura Goussain Darido, Danielle Bruna Leal de Oliveira, Edson Luiz Durigon, Maria CecÃlia Rui Luvizotto, Hans Christian Ackerman, Claudio Romero Farias Marinho,
and et al. 2025. "Angiotensin-Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection" International Journal of Molecular Sciences 26, no. 16: 7663.
https://doi.org/10.3390/ijms26167663
APA Style
da Silva-Santos, Y., Pagni, R. L., Gamon, T. H. M., de Azevedo, M. S. P., Darido, M. L. G., de Oliveira, D. B. L., Durigon, E. L., Luvizotto, M. C. R., Ackerman, H. C., Marinho, C. R. F., Carvalho, L. J. d. M., & Epiphanio, S.
(2025). Angiotensin-Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection. International Journal of Molecular Sciences, 26(16), 7663.
https://doi.org/10.3390/ijms26167663
